Neovascular Glaucoma with Ocular Ischemia in Superior Vena Cava Syndrome.
10.3341/jkos.2012.53.9.1346
- Author:
Ji Hoon JEON
1
;
Kyong Jin CHO
;
Ki Cheol CHANG
;
Moo Hwan CHANG
Author Information
1. Department of Ophthalmology, Dankook University Medical College, Cheonan, Korea. changmh@dankook.ac.kr
- Publication Type:Case Report
- Keywords:
Neovascular glaucoma;
Superior vena cava syndrome
- MeSH:
Antibodies, Monoclonal, Humanized;
Choroid;
Dilatation;
Eye;
Fluorescein Angiography;
Follow-Up Studies;
Glaucoma, Neovascular;
Humans;
Intraocular Pressure;
Ischemia;
Male;
Ophthalmic Solutions;
Small Cell Lung Carcinoma;
Superior Vena Cava Syndrome;
Vena Cava, Superior;
Visual Acuity;
Bevacizumab
- From:Journal of the Korean Ophthalmological Society
2012;53(9):1346-1351
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To report a case of neovascular glaucoma (NVG) with ocular ischemia in superior vena cava syndrome (SVCS). CASE SUMMARY: A 57-year old male who had been treated for small cell lung cancer (SCLC) visited our hospital because of SVCS-like symptoms and decreased visual acuity in the right eye. On the initial examination, best corrected visual acuity was 0.5, intraocular pressure (IOP) was 38 mm Hg and relative afferent papillary defect was positive in the right eye. Slit lamp examination showed mild dilatation and tortuosity of the episcleral vessels and ruobeosis iridis. Gonioscopic examination showed neovascularization of the opened angle. Fluorescein angiography showed delayed choroidal filling and nevascularization of the disc. The patient was diagnosed with NVG with ocular ischemia in SVCS and was treated with chemotherapy and steroid therapy. In addition, intravitreal bevacizumab and IOP lowering eyedrops were administered to the right eye. During follow-up, neovascularizations disappeared and IOP was well controlled. CONCLUSIONS: NVG with ocular ischemia in SVCS should be considered as a possible cause of high IOP in SCLC patients.
